These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Systematic review on urine albumin testing for early detection of diabetic complications. Newman DJ; Mattock MB; Dawnay AB; Kerry S; McGuire A; Yaqoob M; Hitman GA; Hawke C Health Technol Assess; 2005 Aug; 9(30):iii-vi, xiii-163. PubMed ID: 16095545 [TBL] [Abstract][Full Text] [Related]
5. Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria. Marre M; Chatellier G; Leblanc H; Guyene TT; Menard J; Passa P BMJ; 1988 Oct; 297(6656):1092-5. PubMed ID: 2848604 [TBL] [Abstract][Full Text] [Related]
6. Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study. Ravid M; Lang R; Rachmani R; Lishner M Arch Intern Med; 1996 Feb; 156(3):286-9. PubMed ID: 8572838 [TBL] [Abstract][Full Text] [Related]
7. Low-dose angiotensin converting enzyme inhibitors: effect on renal function in normo- and hypertensive type 1 diabetic patients. Ciavarella A; Mustacchio A; Silletti A; Franchi R; Levorato M; Campieri C; Borgnino LC; Capozzi G; Morotti L; Vannini P Eur J Med; 1992 Sep; 1(5):268-72. PubMed ID: 1341608 [TBL] [Abstract][Full Text] [Related]
8. The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group. Laffel LM; McGill JB; Gans DJ Am J Med; 1995 Nov; 99(5):497-504. PubMed ID: 7485207 [TBL] [Abstract][Full Text] [Related]
9. Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease. Sasongko TH; Nagalla S; Ballas SK Cochrane Database Syst Rev; 2013 Mar; (3):CD009191. PubMed ID: 23543572 [TBL] [Abstract][Full Text] [Related]
10. Angiotensin converting enzyme inhibitors in diabetic patients with microalbuminuria or normoalbuminuria. Viberti G; Chaturvedi N Kidney Int Suppl; 1997 Dec; 63():S32-5. PubMed ID: 9407417 [TBL] [Abstract][Full Text] [Related]
11. Renal protection and angiotensin converting enzyme inhibition in microalbuminuric type I and type II diabetic patients. Cooper ME J Hypertens Suppl; 1996 Dec; 14(6):S11-4. PubMed ID: 9023709 [TBL] [Abstract][Full Text] [Related]
12. Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. The EUCLID Study Group. Lancet; 1997 Jun; 349(9068):1787-92. PubMed ID: 9269212 [TBL] [Abstract][Full Text] [Related]
13. Microalbuminuria: a marker to increased renal and cardiovascular risk in diabetes mellitus. McKenna K; Thompson C Scott Med J; 1997 Aug; 42(4):99-104. PubMed ID: 9507584 [TBL] [Abstract][Full Text] [Related]
15. Effective postponement of diabetic nephropathy with enalapril in normotensive type 2 diabetic patients with microalbuminuria. Ahmad J; Siddiqui MA; Ahmad H Diabetes Care; 1997 Oct; 20(10):1576-81. PubMed ID: 9314638 [TBL] [Abstract][Full Text] [Related]
17. Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? A meta-analysis of individual patient data. ACE Inhibitors in Diabetic Nephropathy Trialist Group Ann Intern Med; 2001 Mar; 134(5):370-9. PubMed ID: 11242497 [TBL] [Abstract][Full Text] [Related]
18. Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease. Sasongko TH; Nagalla S; Ballas SK Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD009191. PubMed ID: 26041152 [TBL] [Abstract][Full Text] [Related]
19. Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on All-Cause Mortality and Renal Outcomes in Patients with Diabetes and Albuminuria: a Systematic Review and Meta-Analysis. Wang K; Hu J; Luo T; Wang Y; Yang S; Qing H; Cheng Q; Li Q Kidney Blood Press Res; 2018; 43(3):768-779. PubMed ID: 29794446 [TBL] [Abstract][Full Text] [Related]
20. Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study. Parving HH; Jacobsen P; Tarnow L; Rossing P; Lecerf L; Poirier O; Cambien F BMJ; 1996 Sep; 313(7057):591-4. PubMed ID: 8806248 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]